Navigation Links
Breakthrough in combating the side effects of quinine
Date:6/29/2009

Discovered back in the 1600s quinine was the first effective treatment in the fight against malaria and it continues to be a commonly used treatment against this devastating disease. But the drug is associated with a long list of side effects which can range from sickness and headaches to blindness, deafness and in rare cases death and until now no one knew why.

Scientists at The University of Nottingham have made a discovery that may explain many of the adverse side-effects associated with the drug and as a result have potentially found a way of combating them.

Their research, funded by The Sir Halley Stewart Trust, found that quinine can block a cell's ability to take up the essential amino acid tryptophan. The findings, published today in the Journal of Biological Chemistry, suggest that dietary tryptophan supplements could be a cheap and simple way to improve the performance of this important drug.

Dr Simon Avery and colleagues in the School of Biology used yeast genetics to examine the effects of quinine on a collection of 6000 yeast mutants, each one lacking exactly one of the yeast's 6000 genes. While quite different from humans, yeast is comparable on a cellular level and yeast is frequently, and successfully, used as a front-line agent in testing chemicals and small molecule drugs.

This detailed screening process revealed that strains of yeast unable to make tryptophan were extremely susceptible to quinine poisoning, which led them to identify a tryptophan transporter as a key quinine target (yeast that cannot make their own tryptophan have to rely exclusively on external sources, and thus die if tryptophan transport is blocked).

This discovery fits in well with evidence that quinine reactions are more severe in malnourished individuals. Tryptophan is an essential amino acid which means the human body cannot produce it we have to get it from the food we eat. Tryptophan is abundant in meat but limit
'/>"/>

Contact: Dr. Simon Avery
simon.avery@nottingham.ac.uk
44-011-595-13315
University of Nottingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. On 30th Anniversary, Angioplasty Celebrated as Modern Medical Breakthrough in Stopping Heart Attack
2. drugstore.com and Revolution Health Group Announce Breakthrough Deal
3. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
4. CBaySystems Introduces CBayPraxis - A Breakthrough Solution Focused on Physician Practice Efficiency
5. Oosight Imaging System Enables a Breakthrough: The Viable Transfer of Genetic Material for Stem Cell Nuclear Reprogramming in Primates
6. Breakthrough in organ rejection diagnosis examines gene behavior
7. Safe Sex Passport Launches to Provide Breakthrough Protection Against STDs and HIV
8. Major breakthrough toward the treatment of HIV/HAART-associated Lipodystrophy Syndrome
9. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
10. TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007
11. California Breakthrough a Pivotal Moment in Fight to Transform Nations Health Care System

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... InhibOx, a leading developer of novel and effecti...oined forces with MolPort, an innovator in rare ch... chemical trading platform and builds database of ...his database and its updates to computational chem... virtual screening procedures. Once they identify ...
(Date:12/4/2009)...Plantar fasciitis heel pain affects over two milli... therapy has been cited by the American Academy of...ion. In response to these findings, Orthotics And... therapy systems for plantar fasciitis treatment a...lint therapies. , (PRWEB)...
(Date:12/4/2009)...f., Dec. 4 Herpes zoster, also kno...ve been vaccinated against chicken pox, according ... of the Pediatric Infectious Diseases Journal. ,...tronic health records to identify more than 170,00...pox) vaccine from 2002 to 2008 in Kaiser Permanent...
(Date:12/3/2009)...With a membership increase of more than 15 percent...ly as a milestone in its history, but also as a si...ociations are experiencing a decline in membership...when trade organizations across the nation are suf... unprecedented growth, signaling that physicians s...
(Date:12/3/2009)....J., Dec. 3 The development of Uni...(UMCPP) reached a milestone today with a "topping ...me construction at the new hospital that will repl... ,, (Photo: http://www.newscom.com/cgi-bin/prn...is a steelworkers, tradition in which a steel beam...
Breaking Medicine News(10 mins):Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Florida Medical Association Marks Record Membership Growth 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4
...cardiologist from the University of Alabama, Birmi...bility trial that the drug showed no significant d... users and those taking similar drugs or placebos....t 28,000 patients, contained no evidence that Viox...
...amining the heart and making a correct diagnosis c...er than medical students, residents, and other pra...xamination and in accurately identifying abnormal ...ka M. Vukanovic-Criley, from Stanford University i...
... that smoking and drinking at an early age could l...e adverse effects of tobacco and alcohol has on ou...eading cause of cancer deaths, and doctors general... portal HealthDay News. Researchers led by Dr. ...
...ituminous coal, which is comparable to Jet A or mi...icopter jet engine and can now be used for propell...fuel scientist. // "Because the fuel is 50 p...nce and director of Penn State's Energy Institute....
...port by the UNH scientist, the beginning of 'natur... effect, which is a result of global warming, has ...hereby creating a ripple effect in all the happeni...ther Nature is increasingly getting a jumpstart on...
...an Singh has announced the launch of an ambitious ... five institutions in order to train around 5,000 ...seeks to address the inequalities in healthcare be...ti-disciplinary knowledge through a network of pub...
Other Medicine News:Health News:Could Long Tern Vioxx Users Suffer From Heart Attacks? 2Health News:Jets Can Now Be Propelled By Coal-based Fuel 2Health News:‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scienti 2Health News:‘Natural Spring’ Starts A Week Ahead Now Than Before: UNH Scienti 3
(Date:12/3/2009)...NEW YORK, Dec. 3 Guidepoint Globa...nounced the launch of their Sleep Apnea Tracker, a...nd projects trends and market share in the worldwi...ker captures actual patient usage for 87 different... from 15 different equipment providers going back ...
(Date:12/3/2009)..., DOYLESTOWN, Pa., Dec. 3 /PRNewswire-FirstCall/...rporation, (Nasdaq: QGLY ) www.quigleyco.com an...valuation of its opportunities to develop prescrip...uded that it is in its best interests to focus pri... may include but are not limited to its Cold-EEZE&...
(Date:12/3/2009)..., FORT WORTH, Texas, Dec. 3 /PRNewswire-First...C Bulletin Board: WNDM), a rapidly growing provide...n agreement with the Health Industry Representativ...ndependent sales and marketing representative to m...ct within the U.S. ,, HIRA will market and sel...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cooper Martin Unveils Innovative Stylish Recovery Clothing for Those with Limited Mobility 48188 1Cooper Martin Unveils Innovative Stylish Recovery Clothing for Those with Limited Mobility 48188 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 1Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 3Researchers work to boost effectiveness of the flu vaccine 48184 1Researchers work to boost effectiveness of the flu vaccine 48184 2Researchers work to boost effectiveness of the flu vaccine 48184 3
...rnal of Clinical Lipidology publishes largest stud.../simvastatin to statin therapies using FDA databas...creased cancer risk with ezetimibe mono and ezetim...o cancer rates of other powerful lipid-lowering st...ical Center lipid and health policy experts, was p...
...ERUSALEM, March 25 Oramed Pharmaceuticals,Inc. (O...per of oral delivery,systems, announced today that...the study, entitled, "Open Label Study to Assess t...cs (PD) of Oral Insulin Formulations,in Subjects w...nnual American,Diabetes Association,s Scientific S...
Other Medicine Technology:Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows 2Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA) 2
Optima III Noninsulated Allis Tooth Grasper, without ratchet
Optima III Noninsulated Duck-Bill Grasper, with ratchet
Uninsulated locking handle
Snap-In Snap-Out®-II Single Ring Handle, ratcheted, noninsulated handle, insulated shaft
Medicine Products: